Biopure Harvard Business Case

Over the past two decades, pharmaceutical companies have quietly invaded American’s homes by introducing new miracle drugs such as OxyContin into their daily lives. Purdue Pharmaceuticals introduced OxyContin saying it was a miracle cure for pain that would last twelve hours. However, “even when doctors began reporting that patients were complaining

Biometra is a small company based in the Boston suburb of Woburn which was recently acquired by Scientific Materials (SciMat), in order to deepen its portfolio in vascular medical devices. Biometra focused chiefly on catheters, or tubes used to drain or inject fluids or to allow access of surgical instruments for medical procedures. The catheter would be the first product ever launched by Biometra and so its success was critical for both the companies.

Immediately after the introduction Oxycontin, Purdue Pharma exerted its maximum effort to ensure that billions of dollars worth of Oxycontin were sold. Free products such as hats, coffee mugs, all expense paid conferences, and luxuries for numerous doctors and nurses in attendance at

In the early 1990’s many doctors were hesitant in prescribing narcotics because they were seen as harmful and habit forming. Purdue Pharma the creator of OxyContin changed the ways of the drug industry. Purdue changed the mindset of many physicians and family doctors inconveniencing them that the new to the market drug was revolutionary, with promises of quick pain relief that last up to 12 hours. With marketing adds like “Remember, effective relief just takes two” Purdue Pharma convinced doctors that it was virtually impossible to become addicted (HARRIET RYAN, 2016). The rise of OxyContin started in 1996. OxyContin

1. In no more than one-page, describe Biometra and the industry that this company is in.

1. Describe the function of the following pieces of safety equipment and how each might be used: (10 points)

Bioethics is a very diverse and subjective issue in Buddhism that bases its self around fundamental Buddhist laws such as the five precepts, the four Noble Truths and The Noble Eightfold path. Each Buddhist variant approaches bioethics differently based on the variants primary goal, ideals or practices. However all Buddhists views of bioethics are somewhat influenced by the universal goal of Buddhism to become liberated from the constant cycle of reincarnation or samsara. In conjecture with Buddhism, the occurrence of samsara allows for one to attain a new view on everything including bioethics allowing for the chance to discover or come to an ultimate realisation which in turn allows for the ultimate realisation of issues relating to

Prescription drug prices are on the rise in the United States. Currently, the United States does not implement a price control on prescription drugs. Every day the supply and demand for prescription drugs fluctuates. Pharmaceutical companies produce drugs that are necessary for survival. Therefore, it is necessary for research and development to continue in the United States. Those suffering the effects of exorbitant prices must do so until a generic form of a prescription drug is produced. Once approved by the FDA, new drugs will make their appearance on the market and patients will no longer suffer financially. Until then, it is necessary for pharmaceutical companies to price their drugs based on the idea of supply and demand. This produces the profit used to fund research. Price controls discourage innovation. If a price control were set in place, of course the price of prescription drugs would decrease. However, the development of new drugs decreases with it. Today’s generation would benefit from lower prices, while future generations would suffer from the loss of drug innovation.

Drug forecasting is a very important and essential process for any drug for multiple reasons:

1. What specific items of capital should be included in the SIVMED’s WACC? Should before-tax or after-tax values be included? Should historical or new values be used? Why?

1.The original motivation behind Bayer’s decision to launch the Makrolon ingredient branding concept was, to give Bayer and it’s partner’s the ability to achieve a differentiation of themselves from the competition and competing products by means of a branding strategy. It was important to Bayer to highlight the advantages of Makrolon and transfer this positive image to the end product with the help of a brand name. With this differentiation it gives the ingredient a unique selling proposition, or USP and encourages the end customer to give preference to products with the Makrolon logo or even keep a look out for this particular product when looking to make a purchase.

A balanced scorecard has four perspectives, Customer perspective, internal business perspective, Innovation and learning perspective, and financial perspectives. By using balanced scorecards, BIOCO knows what the customers needed is. It helps BIOCO to fulfill customers’ need better. For internal business perspective part, BIOCO can clear the corporate vision and strategy. BIOCO can adjust the strategy according to the pervious balanced scorecards. Also the balanced scorecards link everyone in the company and enhance the communications between each other. Meanwhile, Scorecards detailed the company’s business goals to everyone and guide every

Located in South San Francisco, CA, Genentech was started in 1976 by a biochemist Dr. Herbert Boyer and Robert A. Swanson. From 1995-2009 Arthur Levinson had become the CEO of Genentech; presently it is Ian T. Clark. Genentech is a leading biotechnology company, using human genetic information to discover, develop, manufacture and commercialize medicines to treat people with serious or life-threatening medical conditions (2014). Biotechnology is the technology based on the science of cellular and biomolecular processes to develop technologies and products that help improve peoples’ lives and the health of our environment. How biotechnology uses cellular and biomolecular processes are by using molecular mechanisms by which genetic and

Organizational change occurs when a company makes a transition from its current state to some desired future state. Managing organizational change is the process of planning and implementing change in organizations in such a way as to minimize employee resistance and cost to the organization while simultaneously maximizing the effectiveness of the change effort. This paper will present a case study of Minnesota Biolabs, a company that supplied rabbits to the producers of injectable devices and their move from injectable rabbits to Sepsis Detection Test (SDT). Instead of conducting tests in live rabbits, SDT used blood extracted from horseshoe crabs for the tests. After extraction, the crabs were returned to the ocean where they

According to the Biomimicry Institute,”[Biomimicry] seeks sustainable solutions to human challenges by emulating nature 's time-tested patterns and strategies. The goal is to create products, processes, and policies—new ways of living—that are well-adapted to life on earth over the long haul.” To achieve this goal, industry and science have to come together to decreases toxins, decrease net greenhouse gas emissions, provide multi-use structure, find sustainable sourcing, and use returning logistics to monitor their work all while decreasing overall cost. Unfortunately this is a task even more complicated than it sounds, but with the help of The Biomimicry Institute as well as the majority of other Biomimicry organizations founded by Janine Benyus, Biomimicry is making its presence known more and more in our world today. Going beyond being the founder of multiple organizations, Janine Benyus is also an American natural sciences writer, innovation consultant, and author that recognized the forgotten genius in the natural world. To help others see what she saw, she took the concept of biomimicry and turned it into three key elements: Ethos, Reconnection, and Emulation. She then applied it to everything she could until it grew into the popular movement it is today.